Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Madrigal Pharmaceuticals (MDGL) Treasury Shares: 2011-2024

Historic Treasury Shares for Madrigal Pharmaceuticals (MDGL) over the last 6 years, with Dec 2024 value amounting to $499,559.

  • Madrigal Pharmaceuticals' Treasury Shares rose 55.10% to $779,923 in Q3 2025 from the same period last year, while for Sep 2025 it was $779,923, marking a year-over-year increase of 55.10%. This contributed to the annual value of $499,559 for FY2024, which is 32.82% up from last year.
  • Per Madrigal Pharmaceuticals' latest filing, its Treasury Shares stood at $499,559 for FY2024, which was up 32.82% from $376,117 recorded in FY2023.
  • Over the past 5 years, Madrigal Pharmaceuticals' Treasury Shares peaked at $499,559 during FY2024, and registered a low of $376,117 during FY2023.
  • In the last 2 years, Madrigal Pharmaceuticals' Treasury Shares had a median value of $437,838 in 2023 and averaged $437,838.
  • Data for Madrigal Pharmaceuticals' Treasury Shares shows a peak YoY spiked of 32.82% (in 2024) over the last 5 years.
  • Madrigal Pharmaceuticals' Treasury Shares (Yearly) stood at $376,117 in 2023, then skyrocketed by 32.82% to $499,559 in 2024.